HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of an EP2 and EP3 Receptor Dual Agonist, ONO-8055, on a Radical Hysterectomy-Induced Underactive Bladder Model in Monkeys.

AbstractOBJECTIVES:
The objective was to develop an underactive bladder (UAB) model in primates and to evaluate the potential of prostanoid EP2 and EP3 receptor dual agonist ONO-8055 to become a therapeutic agent for UAB.
METHODS:
A surgical procedure resembling radical hysterectomy was performed on female cynomolgus monkeys. Subsequently, in vitro muscle strip studies were performed using bladder muscle strips from normal monkeys and monkeys that underwent surgery. In addition, uroflowmetric data were obtained at specified days after the surgery. To evaluate the effects of ONO-8055 and distigmine (DIS) on voiding function in the UAB monkey model, uroflowmetry was performed approximately 1 week after the surgery, before and after the cumulative intravenous administration of the compounds at 2 h intervals.
RESULTS:
In the bladder muscle strip studies, the responses to potassium chloride at 2 months, and carbachol and electrical field stimulation from 2 weeks decreased significantly. Voided volume (VV), maximum flow rate (Qmax), and average flow rate (Qave) decreased after surgery, while voiding time (VT) increased. In this model, ONO-8055 and DIS significantly increased VV and Qmax. DIS prolonged VT, while ONO-8055 had no effect. The results also showed that ONO-8055 increased Qave.
CONCLUSIONS:
We developed a neurogenic UAB model in primates. As ONO-8055 improved voiding function in this model to at least the same degree as DIS, this EP2 and EP3 receptor dual agonist has the potential to be a candidate for neurogenic UAB pharmacotherapy.
AuthorsHidekazu Matsuya, Noritoshi Sekido, Jun Kida, Hiroko Mashimo, Daisuke Wakamatsu, Hiroki Okada
JournalLower urinary tract symptoms (Low Urin Tract Symptoms) Vol. 10 Issue 2 Pg. 204-211 (May 2018) ISSN: 1757-5672 [Electronic] Australia
PMID28439968 (Publication Type: Journal Article)
Copyright© 2017 John Wiley & Sons Australia, Ltd.
Chemical References
  • Cholinesterase Inhibitors
  • ONO-8055
  • Pyridinium Compounds
  • Receptors, Prostaglandin E, EP2 Subtype
  • Receptors, Prostaglandin E, EP3 Subtype
  • Thiazoles
  • distigmine
Topics
  • Animals
  • Cholinesterase Inhibitors (pharmacology)
  • Disease Models, Animal
  • Female
  • Hysterectomy (methods)
  • Macaca fascicularis
  • Muscle Contraction (drug effects)
  • Pyridinium Compounds (pharmacology)
  • Receptors, Prostaglandin E, EP2 Subtype (antagonists & inhibitors)
  • Receptors, Prostaglandin E, EP3 Subtype (antagonists & inhibitors)
  • Rheology
  • Thiazoles (pharmacology)
  • Urinary Bladder, Neurogenic (drug therapy, physiopathology)
  • Urination (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: